Detalhe da pesquisa
1.
Variability and magnitude of brain glutamate levels in schizophrenia: a meta and mega-analysis.
Mol Psychiatry
; 28(5): 2039-2048, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36806762
2.
Association of Age, Antipsychotic Medication, and Symptom Severity in Schizophrenia With Proton Magnetic Resonance Spectroscopy Brain Glutamate Level: A Mega-analysis of Individual Participant-Level Data.
JAMA Psychiatry
; 78(6): 667-681, 2021 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33881460
3.
Aberrant white matter microstructure in treatment-resistant schizophreniaâ°.
Psychiatry Res Neuroimaging
; 305: 111198, 2020 11 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-33035754
4.
Functional network dysconnectivity as a biomarker of treatment resistance in schizophrenia.
Schizophr Res
; 195: 160-167, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29042073
5.
Does cognitive impairment in treatment-resistant and ultra-treatment-resistant schizophrenia differ from that in treatment responders?
Psychiatry Res
; 230(3): 811-8, 2015 Dec 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-26564550
6.
Pharmacotherapy for treatment-resistant schizophrenia.
Neuropsychiatr Dis Treat
; 7: 135-49, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21552316